TY  - JOUR
AU  - Pasquau, Juan
AU  - de Jesus, Samantha E
AU  - Arazo, Piedad
AU  - Crusells, María J
AU  - Ríos, María J
AU  - Lozano, Fernando
AU  - de la Torre, Javier
AU  - Galindo, María J
AU  - Carmena, Jorge
AU  - Santos, Jesús
AU  - Tornero, Carlos
AU  - Verdejo, Guillermo
AU  - Samperiz, Gloria
AU  - Palacios, Zaira
AU  - Hidalgo-Tenorio, Carmen
AU  - RIDAR Study Group
PY  - 2019
DO  - 10.1186/s12879-019-3817-6
UR  - http://hdl.handle.net/10668/13642
T2  - BMC infectious diseases
AB  - The objective was to analyze the effectiveness and safety of dual therapy with rilpivirine plus boosted-darunavir (RPV + bDRV) in real-life patients. Observational, retrospective, multi-center study in HIV+ patients who had received RPV + bDRV for...
LA  - en
KW  - Darunavir
KW  - Dual therapy
KW  - HIV
KW  - Nuke-sparing regimens
KW  - Rilpivirine
KW  - Simplification
KW  - Adult
KW  - Anti-HIV Agents
KW  - CD4-Positive T-Lymphocytes
KW  - Darunavir
KW  - Drug Therapy, Combination
KW  - Female
KW  - HIV Infections
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Rilpivirine
KW  - Treatment Outcome
KW  - Viral Load
TI  - Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study).
TY  - research article
VL  - 19
ER  -